Global Fertilty Services market: Trends and Growth (8.72% CAGR) Segments Forecast 2016-2020

About Fertility Services

Couples with fertility issues are unable to conceive even after regular unprotected coitus. Infertility complications are widespread, with either female or male infertility factors accounting for one-third of the cases. In the rest of the cases, the cause is either unknown or a combination of both male and female infertility factors. Low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm are some of the factors that can lead to infertility in males. Hormonal changes, fallopian tube damage, endometriosis, and cervical abnormalities are factors that can lead to infertility in women. Diagnosing the cause of infertility can be difficult, but people with fertility issues can choose from a variety of treatment options, depending on the underlying problem.

Technavio’s analysts forecast the global fertility services market to grow at a CAGR of 8.72% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global fertility services market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales and use of infertility drugs and assisted reproductive technology (ART).

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Fertility Services Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Complete report details @ https://www.wiseguyreports.com/reports/417255/global-fertilty-services-market-2016-2020

Key vendors
• Carefertility
• Coopersurgical
• Ferring Pharmaceuticals
• Merck
• MonashIVF
• Vitrolife

Other prominent vendors
• Abbott Laboratories
• AbbVie
• Actavis
• Apricus Biosciences
• AstraZeneca
• Auxogyn
• Bristol-Myers Squibb
• Cell Cura
• Dong-A Socio
• Elelixis Diagnostics
• Eli Lilly
• EMD Serono
• Fertility Focus
• Halotech
• HRA Pharma
• IKS International
• In Vitro Care
• Invo Bioscience
• Irvine Scientific
• IVFtech Aps
• Kitazato
• Life Global
• Medical Electronic Systems
• Meditex
• Microtech IVF
• Nidacon International
• Novartis
• NuSep
• Ovascience
• Pantec Biosolutions
• Pfizer
• PregLem
• Reproductive Health Science
• ReproTech
• Sanofi
• Smiths Medical International
• Sperm Processor
• Vitrolife
• Vivus
• Xytex Cryo International.

Market driver
• Increase in infertility rate and obesity
• For a full, detailed list, view our report

Market challenge
• High cost of fertility treatment
• For a full, detailed list, view our report

Market trend
• Increase in R&D
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/417255/global-fertilty-services-market-2016-2020

Table of Content

PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Infertility: An overview
• Epidemiology
• Signs and symptoms
• Tests and diagnosis
• Treatments
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Stages of fertility treatment
PART 07: Regulatory landscape of ART and IVF
• Reporting requirements
• Regulations governing IVF
• Need for more guidelines and regulations
PART 08: Fertility tourism
PART 09: Cost analysis
• Direct costs
• Indirect costs
• Cost of IVF treatments
PART 10: Market segmentation by type of treatment
• Infertility drugs
• Global infertility drugs market
• ART
• Global ART market
PART 11: Geographical segmentation
• Fertility services market in Americas
• Fertility services market in EMEA
• Fertility services market in APAC
PART 12: Key leading countries
• US
• UK
• Belgium
• China
• India
• Israel
PART 13: Market drivers
• Increase in infertility rate and obesity
• Increase in success rate of infertility treatments
• Growing demand for ART and acceptance of same-sex marriage in developed countries
PART 14: Impact of drivers
PART 15: Market challenges
• High cost of fertility treatments
• Complications related to fertility services
• Ethical, legal, and social issues
• Limited reimbursement
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Increase in R&D
• Establishment of new fertility clinics
• Increase in M&A and collaborations
• Public awareness and government support
• Medical tourism
PART 18: Vendor landscape
• Competitive scenario
• Key news
• Mergers and acquisitions
• Licenses and collaborations
• Key vendor analysis 2015
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio 

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=417255

Contact US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)